Overview
The Harvest Eli Lilly Enhanced High Income Shares ETF invests all its assets in shares of Eli Lilly. Eli Lilly is a leading pharmaceutical company that specializes in the development of medicines for diabetes, cancer, and autoimmune diseases. Its strong portfolio of innovative drugs and focus on R&D makes Eli Lilly a major player in the healthcare sector.
Fund Focus
The Harvest Eli Lilly Enhanced High Income Shares ETF provides access to the growth potential of Eli Lilly and overlays an active covered call writing strategy on up to 50% of the portfolio. It applies modest leverage at around 25% for higher income and growth potential. Units of the ETF are available in CAD (LLHE) and USD (LLHE.U).
Advantages
- US Stock + Higher Monthly Income
- Canadian Trust Unit
- Tax Efficiency
- Lower Purchase Price
- Higher Income in CAD/USD
- Available without leverage
LLY Historical Price
Eli Lilly & Co. (LLY:NYSE) is a dominant global pharmaceutical manufacturer and distributor.
Source: Bloomberg
Fund Details | As at 2024/10/04 |
---|---|
Ticker | LLHE.U |
Reference Asset | LLY |
Distribution (per unit)* | $0.18 / MTH |
NAV | $11.49 |
MKT (Close) | $11.46 |
AUM** | $10.91M |
Currency | USD |
Management Fee | 0.40% |
More Details
CUSIP | 41753X209 |
Inception | 2024/08/21 |
Eligible | RRSP / TFSA / RRIF / RESP / FHSA |
Distribution Frequency | Monthly |
Distribution Method | Cash/DRIP |
Risk Rating | Medium-High |
Similar funds:
LLHE
Harvest Eli Lilly Enhanced High Income Shares ETF
LLYH
Harvest Eli Lilly High Income Shares ETF
LLYH.U
Harvest Eli Lilly High Income Shares ETF
Performance / Distributions
Performance for Harvest High Income Shares ETF cannot be displayed until 1 year after inception 2024/08/21.
* Initial distribution as announced on August 21, 2024 to be paid on October 9, 2024.
Distribution History
Record Date | Ex-dividend Date | Pay Date | Amount | Distribution Frequency | |
---|---|---|---|---|---|
2024/09/27 | 2024/09/27 | 2024/10/09 | $0.1800 | Monthly |
Portfolio Breakdown
The ETF seeks to provide unitholders with long-term capital appreciation through purchasing and holding common stock of LLY and generate high monthly cash distributions through an active covered call writing strategy.
HOLDING | As at September 30, 2024 |
---|---|
Eli Lilly and Company | 127.4% |
Market value of options | (0.5)% |
Cash and other assets and liabilities | (27.0)% |
Disclaimer
Commissions, management fees and expenses all may be associated with investing in Harvest High Income Shares ETFs managed by Harvest Portfolios Group Inc. (the “Funds” or a “Fund”). Please read the relevant prospectus before investing. The Funds’ returns are not guaranteed, their values change frequently, and past performance may not be repeated. Tax investment and all other decisions should be made with guidance from a qualified professional.
Distributions are paid to you in cash unless you request, pursuant to your participation in a distribution reinvestment plan, that they be reinvested into Class A and Class U units of the Fund. If a Fund earns less than the amounts distributed, the difference is a return of capital.
Certain statements included in this communication constitute forward-looking statements (“FLS”, including, but not limited to, those identified by the expressions “expect”, “intend”, “will” and similar expressions to the extent they relate to the Funds. The FLS are not historical facts but reflect the Harvest’s and the portfolio manager of the Funds current expectations regarding future results or events. These FLS are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Although Harvest and the portfolio manager of the Funds believe that the assumptions inherent in the FLS are reasonable, FLS are not guarantees of future performance and, accordingly, readers are cautioned not to place undue reliance on such statements due to the inherent uncertainty therein. The Funds, Harvest and the portfolio manager of the Funds undertake no obligation to update publicly or otherwise revise any FLS or information whether as a result of new information, future events or other such factors which affect this information, except as required by law.
** Represents aggregate AUM of all classes denominated in Canadian dollars.